Displaying 1 to 20 of 29 investments
Country Date Notes
Acusphere Inc
Pharmaceutical firm developing porous micro-particle delivery systems.
United States 1 Apr 2003 N/A
Active
Agensys Inc
United States 1 Jul 2007 Series D
Active
Arena Pharmaceuticals Inc
United States N/A
Broncus Technologies Inc
Developer of interventional bronchoscopy devices for the treatment of chronic lung diseases.
United States 1 Jan 2000 Debt
ChemoCentryx Inc
United States 1 Jun 2004 N/A
Cylene Pharmaceuticals Inc
Clinical stage private company developing small molecule drugs against newly validated cancer targets.
United States 1 Jan 2007 Series C
Active
Cylene Pharmaceuticals Inc
Clinical stage private company developing small molecule drugs against newly validated cancer targets.
United States 1 Sep 2010 Series D
Active
Delenex Therapeutics AG
Switzerland 1 Nov 2010 Series A
Devax Inc
Developer of a drug-eluting stent for the treatment of vascular bifurcations.
United States N/A
Active
Ellipse Technologies Inc
United States 1 Aug 2011 Series C
ESBATech AG
Switzerland based Biomedical Research Unit of Alcon
Switzerland Series B
ESBATech AG
Switzerland based Biomedical Research Unit of Alcon
Switzerland 1 Aug 2006 Series B
Initial investment. Round participant. Active
ESBATech AG
Switzerland based Biomedical Research Unit of Alcon
Switzerland 1 Nov 2002 N/A
Initial investment. Round participant. Active
Icagen Inc
Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases.
United States N/A
Kolltan Pharmaceuticals Inc
Oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases.
United States 1 Oct 2009 Series A
Mpex Pharmaceuticals Inc
United States N/A
Nereus Pharmaceuticals Inc
United States 1 Jun 2010 Series E
Nereus Pharmaceuticals Inc
United States 1 Jan 2005 N/A
Nereus Pharmaceuticals Inc
United States 1 Aug 2007 Series D
Pacira Pharmaceuticals Inc
Acute care specialty pharmaceutical company.
United States N/A